atorvastatin has been researched along with Liver Cirrhosis, Biliary in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carvalho, D; Rodrigues, E; Saavedra, A | 1 |
| Claudel, T; Fauler, G; März, W; Putz-Bankuti, C; Scharnagl, H; Sourij, H; Stauber, RE; Stojakovic, T; Trauner, M; Wagner, M; Wascher, TC; Winkler, K | 1 |
| Fauler, G; Gurakuqi, G; März, W; Putz-Bankuti, C; Scharnagl, H; Stadlbauer, V; Stauber, RE; Stojakovic, T; Trauner, M; Wagner, M | 1 |
| Allina, J; Bach, N; Bodenheimer, H; Bodian, C; Odin, JA; Stanca, CM | 1 |
1 trial(s) available for atorvastatin and Liver Cirrhosis, Biliary
| Article | Year |
|---|---|
Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.
Topics: Atorvastatin; Blood Vessels; Cardiovascular Diseases; Cholestasis; Cholesterol; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Pyrroles | 2010 |
3 other study(ies) available for atorvastatin and Liver Cirrhosis, Biliary
| Article | Year |
|---|---|
[Dyslipidemia Secondary to Hypothyroidism and Cholestasis].
Topics: Atorvastatin; Autoimmune Diseases; Cholestasis; Diabetes Mellitus; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypothyroidism; Liver Cirrhosis, Biliary; Middle Aged; Obesity; Thyroxine; Withholding Treatment | 2020 |
Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Biomarkers; Cholagogues and Choleretics; Cholestasis; Cholesterol; Female; Heptanoic Acids; Humans; Lipoproteins, LDL; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Pyrroles; Single-Blind Method; Transaminases; Ursodeoxycholic Acid | 2007 |
Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosis.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Lipids; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Pyrroles; Quality of Life; Retrospective Studies; Treatment Outcome | 2008 |